High materiality7/10
AbbVie price target raised to $320 from $280 at Scotiabank
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
AbbVie target raised; current price around $265.21 supports a bullish view.
- ABBV target raised; bullish setup.
Key facts
- 01
Target: $320
- 02
Posted price: $265.21
- 03
Analyst firm: Scotiabank
- 04
Analyst: Louise Chen
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.